Patents by Inventor Gerald A. Maguire, MD

Gerald A. Maguire, MD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sublingual Delivery for Mitigation of Side Effects Associated with Zicronapine
    Publication number: 20230114360
    Abstract: Sublingual delivery vehicles (SDVs) including tablets and gel strips may mitigate or eliminate side effects associated with active ingredients included in the SDVs. An exemplary SDV may include: an ingredient mixture including a flavoring agent and a lubricant; and a specified dose of zicronapine, wherein the SDV dissolves within thirty seconds of sublingual administration. A method of manufacturing an SDV may include mixing a set of ingredients, wherein the set of ingredients includes: a flavoring agent, a lubricant, and a specified dose of zicronapine; and forming the SDV from the mixed set of ingredients. A method for treating mental disorders may include administering, once a day, an ingredient mixture including: a flavoring agent; a lubricant; and a specified dose of zicronapine, wherein the ingredient mixture is administered via a sublingual delivery vehicle (SDV).
    Type: Application
    Filed: December 13, 2022
    Publication date: April 13, 2023
    Applicants: Vivera Pharmaceuticals Inc., Vivera Pharmaceuticals Inc.
    Inventors: Paul Edalat, Gerald A. Maguire, MD, Stephen J. McColgan, MD